Literature DB >> 26890830

Safety and technique of ferumoxytol administration for MRI.

Shreyas S Vasanawala1, Kim-Lien Nguyen2, Michael D Hope3, Mellena D Bridges4, Thomas A Hope3, Scott B Reeder5, Mustafa R Bashir6.   

Abstract

Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  contrast agent; ferumoxytol; iron oxide; safety

Mesh：

Substances：

Year:  2016        PMID： 26890830      PMCID： PMC4854636          DOI： 10.1002/mrm.26151

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN： 0740-3194            Impact factor:   4.668


  52 in total

1.  A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI.

Authors:  Martin R Prince; Hong Lei Zhang; Shalini G Chabra; Paula Jacobs; Yi Wang
Journal:  J Xray Sci Technol       Date:  2003-01-01       Impact factor: 1.535

2.  Mathematical optimization of contrast concentration for T1-weighted spoiled gradient echo imaging.

Authors:  Scott B Reeder; Matthew R Smith; Diego Hernando
Journal:  Magn Reson Med       Date:  2015-05-18       Impact factor: 4.668

3.  Interleukin-6 involvement in brain arteriovenous malformations.

Authors:  Yongmei Chen; Ludmila Pawlikowska; Jianhua S Yao; Fanxia Shen; Wenwu Zhai; Achal S Achrol; Michael T Lawton; Pui-Yan Kwok; Guo-Yuan Yang; William L Young
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

4.  Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors.

Authors:  Eric M Thompson; Daniel J Guillaume; Edit Dósa; Xin Li; Kellie J Nazemi; Seymur Gahramanov; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2012-04-19       Impact factor: 4.130

5.  A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.

Authors:  Markus R Jahn; Hans B Andreasen; Sören Fütterer; Thomas Nawroth; Volker Schünemann; Ute Kolb; Wolfgang Hofmeister; Manuel Muñoz; Klaus Bock; Morten Meldal; Peter Langguth
Journal:  Eur J Pharm Biopharm       Date:  2011-03-23       Impact factor: 5.571

6.  Nephrogenic Systemic Fibrosis Manifesting a Decade After Exposure to Gadolinium.

Authors:  Krista N Larson; Amy L Gagnon; Melissa D Darling; James W Patterson; Thomas G Cropley
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

7.  Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival.

Authors:  Seymur Gahramanov; Leslie L Muldoon; Csanad G Varallyay; Xin Li; Dale F Kraemer; Rongwei Fu; Bronwyn E Hamilton; William D Rooney; Edward A Neuwelt
Journal:  Radiology       Date:  2012-11-30       Impact factor: 11.105

8.  High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.

Authors:  Anjali B Nayak; Aarti Luhar; Mark Hanudel; Barbara Gales; Theodore R Hall; J Paul Finn; Isidro B Salusky; Joshua Zaritsky
Journal:  Pediatr Nephrol       Date:  2014-09-12       Impact factor: 3.714

Review 9.  MR angiography with blood pool contrast agents.

Authors:  Jens Bremerich; Deniz Bilecen; Peter Reimer
Journal:  Eur Radiol       Date:  2007-07-17       Impact factor: 5.315

10.  Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases.

Authors:  Zhitong Zou; Lin Ma
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494
View more
  68 in total

Review 1.  Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.

Authors:  Jawad Fares; Deepak Kanojia; Aida Rashidi; Atique U Ahmed; Irina V Balyasnikova; Maciej S Lesniak
Journal:  Clin Breast Cancer       Date:  2019-06-05       Impact factor: 3.225

2.  Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.

Authors:  Baris Turkbey; Marcin Czarniecki; Joanna H Shih; Stephanie A Harmon; Piyush K Agarwal; Andrea B Apolo; Deborah E Citrin; James L Gulley; Mukesh Harisinghani; Ravi A Madan; Adam R Metwalli; Edmond Paquette; Peter A Pinto; Soroush Rais-Bahrami; Lindsay S Rowe; Bradford J Wood; Paula M Jacobs; Liza Lindenberg; William Dahut; Peter L Choyke
Journal:  AJR Am J Roentgenol       Date:  2019-10-15       Impact factor: 3.959

Review 3.  Safety issues related to intravenous contrast agent use in magnetic resonance imaging.

Authors:  Skorn Ponrartana; Michael M Moore; Sherwin S Chan; Teresa Victoria; Jonathan R Dillman; Govind B Chavhan
Journal:  Pediatr Radiol       Date:  2021-04-19

Review 4.  Noncontrast MR angiography: An update.

Authors:  Robert R Edelman; Ioannis Koktzoglou
Journal:  J Magn Reson Imaging       Date:  2018-12-19       Impact factor: 4.813

Review 5.  Laminar fMRI: What can the time domain tell us?

Authors:  Natalia Petridou; Jeroen C W Siero
Journal:  Neuroimage       Date:  2017-07-20       Impact factor: 6.556

Review 6.  Cross-sectional imaging of congenital pulmonary artery anomalies.

Authors:  Evan J Zucker
Journal:  Int J Cardiovasc Imaging       Date:  2019-06-07       Impact factor: 2.357

Review 7.  Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

Authors:  Alicia S Borggreve; Lucas Goense; Hylke J F Brenkman; Stella Mook; Gert J Meijer; Frank J Wessels; Marcel Verheij; Edwin P M Jansen; Richard van Hillegersberg; Peter S N van Rossum; Jelle P Ruurda
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

8.  Dextran-Coated Iron Oxide Nanoparticles as Biomimetic Catalysts for Localized and pH-Activated Biofilm Disruption.

Authors:  Pratap C Naha; Yuan Liu; Geelsu Hwang; Yue Huang; Sarah Gubara; Venkata Jonnakuti; Aurea Simon-Soro; Dongyeop Kim; Lizeng Gao; Hyun Koo; David P Cormode
Journal:  ACS Nano       Date:  2019-01-22       Impact factor: 15.881

Review 9.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Authors:  Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt
Journal:  Kidney Int       Date:  2017-04-20       Impact factor: 10.612

10.  Gated thoracic magnetic resonance angiography at 3T: noncontrast versus blood pool contrast.

Authors:  Chengcheng Zhu; Henrik Haraldsson; Kimberly Kallianos; Liang Ge; Elaine Tseng; Travis Henry; David Saloner; Michael D Hope
Journal:  Int J Cardiovasc Imaging       Date:  2017-09-13       Impact factor: 2.357
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.